Literature DB >> 34320364

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution.

Mengqing Gao1, Jin Wang2, Sophie Rousseaux3, Minjia Tan4, Lulu Pan4, Lijun Peng2, Sisi Wang2, Wenqian Xu2, Jiayi Ren2, Yuanfang Liu5, Martin Spinck6, Sophie Barral3, Tao Wang3, Florent Chuffart3, Ekaterina Bourova-Flin3, Denis Puthier7, Sandrine Curtet3, Lisa Bargier7, Zhongyi Cheng8, Heinz Neumann6, Jian Li9, Yingming Zhao10, Jian-Qing Mi11, Saadi Khochbin12.   

Abstract

In addition to acetylation, histones are modified by a series of competing longer-chain acylations. Most of these acylation marks are enriched and co-exist with acetylation on active gene regulatory elements. Their seemingly redundant functions hinder our understanding of histone acylations' specific roles. Here, by using an acute lymphoblastic leukemia (ALL) cell model and blasts from individuals with B-precusor ALL (B-ALL), we demonstrate a role of mitochondrial activity in controlling the histone acylation/acetylation ratio, especially at histone H4 lysine 5 (H4K5). An increase in the ratio of non-acetyl acylations (crotonylation or butyrylation) over acetylation on H4K5 weakens bromodomain containing protein 4 (BRD4) bromodomain-dependent chromatin interaction and enhances BRD4 nuclear mobility and availability for binding transcription start site regions of active genes. Our data suggest that the metabolism-driven control of the histone acetylation/longer-chain acylation(s) ratio could be a common mechanism regulating the bromodomain factors' functional genomic distribution.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34320364     DOI: 10.1016/j.celrep.2021.109460

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  7 in total

Review 1.  Large-Scale Chromatin Rearrangements in Cancer.

Authors:  Kosuke Yamaguchi; Xiaoying Chen; Asami Oji; Ichiro Hiratani; Pierre-Antoine Defossez
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

Review 2.  NUT Is a Driver of p300-Mediated Histone Hyperacetylation: From Spermatogenesis to Cancer.

Authors:  Sophie Rousseaux; Nicolas Reynoird; Saadi Khochbin
Journal:  Cancers (Basel)       Date:  2022-04-29       Impact factor: 6.575

Review 3.  PQBP1: The Key to Intellectual Disability, Neurodegenerative Diseases, and Innate Immunity.

Authors:  Hikari Tanaka; Hitoshi Okazawa
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

Review 4.  NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review.

Authors:  Wenyi Luo; Todd M Stevens; Phillip Stafford; Markku Miettinen; Zoran Gatalica; Semir Vranic
Journal:  Curr Oncol       Date:  2021-11-07       Impact factor: 3.677

5.  A Nutrient-Based Cellular Model to Characterize Acetylation-Dependent Protein-Protein Interactions.

Authors:  Jérémy Loehr; Pata-Eting Kougnassoukou Tchara; Kevin Gonthier; Chahinez Noufi; Naomie Linteau; Étienne Audet-Walsh; Jean-Philippe Lambert
Journal:  Front Mol Biosci       Date:  2022-03-23

6.  Class I histone deacetylases (HDAC1-3) are histone lysine delactylases.

Authors:  Carlos Moreno-Yruela; Di Zhang; Wei Wei; Michael Bæk; Wenchao Liu; Jinjun Gao; Daniela Danková; Alexander L Nielsen; Julie E Bolding; Lu Yang; Samuel T Jameson; Jiemin Wong; Christian A Olsen; Yingming Zhao
Journal:  Sci Adv       Date:  2022-01-19       Impact factor: 14.136

7.  ATAD2 controls chromatin-bound HIRA turnover.

Authors:  Tao Wang; Daniel Perazza; Fayçal Boussouar; Matteo Cattaneo; Alexandre Bougdour; Florent Chuffart; Sophie Barral; Alexandra Vargas; Ariadni Liakopoulou; Denis Puthier; Lisa Bargier; Yuichi Morozumi; Mahya Jamshidikia; Isabel Garcia-Saez; Carlo Petosa; Sophie Rousseaux; André Verdel; Saadi Khochbin
Journal:  Life Sci Alliance       Date:  2021-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.